Header graphic for print
Focus on Regulation

Tag Archives: Sunshine Act

Belgian sunshine rules – Submissions required by 31 May 2018 at the latest

On 27 December 2016, the Belgian Law of 18 December 2016 concerning various health-related matters (“the Sunshine Act”) was adopted by the Belgian Ministry for Public Health. The Sunshine Act provides that life sciences companies must publically disclose information concerning all pecuniary advantages or benefits in kind granted, directly or indirectly from Belgium or elsewhere,

CMS Posts New Open Payments FAQs

The Centers for Medicare and Medicaid Services (CMS) recently released nineteen new FAQs on the Open Payments Program, under the Federal Physician Payments Transparency Act.  Effective August 1, 2013, applicable manufacturers will need to begin tracking payments and transfers of value under the Open Payments Program (also known as the federal Sunshine requirements).  The new

Dutch Sunshine Act: Financial relations between pharmaceutical companies and healthcare professionals will be made public in the Netherlands in April

As of 10 April 2013, the transparency register regarding financial relations between pharmaceutical companies and healthcare professionals in the Netherlands will go live.  Through the register, anybody from patients and journalists to competitors will be able to search per healthcare professional or per organization of healthcare professionals for financial relations with pharmaceutical industry.  The self-regulatory

Sunshine Regulations to Unmask PODs’ Financial Relationships

The final Sunshine regulations, published in the Federal Register on February 8, require applicable manufacturers (“AMs”) and applicable GPOs (“AGPOs”) to submit reports on physician ownership and investment interests.  Notably, the regulations require physician-owned distributors of covered products (including implantable medical devices) (“PODs”) to collect and report information on their financial relationships with their physician

Final Rule to Implement Physician Payment Sunshine Act Released

Today, the Centers for Medicare and Medicaid Services (CMS) released the final rule to implement the federal Physician Payment Sunshine Act (commonly known as the Sunshine Act).  The Sunshine Act requires applicable manufacturers of drugs, devices, biologicals, and medical supplies to track and publicly report payments and other transfers of value that they make to physicians